Vitamin D deficiency as a risk factor of uncontrolled asthma
https://doi.org/10.18093/0869-0189-2017-27-5-624-628
Abstract
The aim of this study was to determine a relationship between IL-17, IL-10 and vitamin D concentrations and asthma control level in adult patients.
Methods. This was a comparative study which involved 79 asthma patients. The patients were divided in two groups: 48 patients with good control of asthma (mean age, 52 ± 13 years; BMI, 24.9 (21.6 – 28.3) kg/m2) and 31 patients with uncontrolled asthma (mean age, 57.6 ± 7.9 years; BMI, 29.1 (27.3 – 33.6) kg/m2). Concentrations of IL-10, IL-17 and vitamin D were measured in blood serum using ELISA assay.
Results. Vitamin D concentration was significantly lower in patients with uncontrolled asthma compared to well-controlled asthma. An inverse relationship was found between vitamin D and IL-17 blood concentrations but not between vitamin D and IL-10 blood concentrations.
Conclusion. Serum concentration of vitamin D could be used as a predictor of asthma course and control.
About the Authors
V. I. KupaevRussian Federation
Doctor of Medicine, Professor, Head of Department of Family Medicine
tel.: 927-256-09-27
Chapaevskaya ul. 89, Samara, 443099, Russia
M. S. Nurdina
Russian Federation
PhD student, Department of Family Medicine
tel.: 917-824-07-79
Chapaevskaya ul. 89, Samara, 443099, Russia
L. V. Limareva
Russian Federation
Assistant Professor, Leading Researcher, Institute of Experimental Medicine and Biotechnologies
tel.: 905-017-89-92
Chapaevskaya ul. 89, Samara, 443099, Russia
References
1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2016 update. Available at: www.ginasthma.org
2. Nagatkin D.A. Effects of sublingual immune therapy on asthma control level. Aspirantskiy vestnik Povolzh'ya. 2013; (5-6): 53–56 (in Russian).
3. Drobik O.S., Biteeva D.V. Uncontrolled asthma: ways to resolve the problem. Astma i allergologiya. 2013; (4): 11–18 (in Russian).
4. Budnevskiy A.V., Chernov A.V., Ermolova A.V., Tribuntseva L.V. Bronchial asthma with co-morbid metabolic syndrome: opportunity to achieve control of the disease. Pul'monologiya. 2014; (5): 39–45. DOI: 10.18093/0869-0189-2014-0-5-39-45 (in Russian).
5. Nenasheva N.M. Federal clinical guidelines on diagnosis and therapy of bronchial asthma, 2016: what is new? Prakticheskaya pul'monologiya. 2016; (3): 3–10 (in Russian).
6. Allain T.J., Dhesi J. Hypovitaminosis D in older adults. Gerontology. 2003; 49 (5): 273–278. DOI: 10.1159/000071707.
7. Wenzel S.E. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat. Med. 2012; 18 (5): 716–725. DOI: 10.1038/nm.2678.
8. Kurbacheva O.M., Zhestkov A.V., Nagatkin D.A. et al. Current view of immunopathogenesis of bronchial asthma. Rossiyskiy allergologicheskiy zhurnal. 2016; (2): 10–14 (in Russian).
9. Dimitrov V., White J.H. Species-specific regulation of innate immunity by vitamin D signaling. J. Steroid. Biochem. Mol. Biol. 2016; 164: 164–253. DOI: 10.1016/j.jsbmb.2015.09.016.
10. Teske K.A., Bogart J.W., Sanchez L.M. et al. Synthesis and evaluation of vitamin D receptor-mediated activities of cholesterol and vitamin D metabolites. Eur. J. Med. Chem. 2016; 109: 238–246. DOI: 10.1016/j.ejmech.2016.01.002.
11. Shalaby Samaha H. M., Elsaid A. R., NasrEldin E. Vitamin D and markers of airway inflammation in asthma. Egypt. J. Chest Dis. Tuber. 2015; 64 (4): 779–783. DOI: 10.1016/j.ejcdt.2015.03.027.
12. Prietl B., Treiber G., Pieber T.R., Amrein K. Vitamin D and immune function. Nutrients. 2013; 5 (7): 2502–2521. DOI: 10.3390/nu5072502
Review
For citations:
Kupaev V.I., Nurdina M.S., Limareva L.V. Vitamin D deficiency as a risk factor of uncontrolled asthma. PULMONOLOGIYA. 2017;27(5):624-628. (In Russ.) https://doi.org/10.18093/0869-0189-2017-27-5-624-628